Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort

Lung cancer is the most frequent cancer worldwide, and is associated to 1.6 million annual deaths [1]. Among the different histological types of lung cancer, non-small cell lung cancer (NSCLC) is the most common (80 –85%). Stage III, locally-advanced disease is diagnosed in about one third of patients with a diagnosis of lung cancer. In such situations, radical resection is generally not possible because tissues adjacent to the primary tumor or lymph nodes are invaded by tumor cells [2,3].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research